Texas Universities Come Together to Develop Novel Nanoparticle for Pancreatic Cancer Diagnosis and Treatment

Rice University, Baylor College, and the University of Texas to develop approach to test the specially engineered nanoparticle
The preclinical testing program, which will be implemented over the next five years, will be funded through $1.8 million grant from the National Cancer Institute's (NCI) Alliance for Nanotechnology in Cancer program. The research team will include scientists and researchers from Rice University's Laboratory for Nanophotonics (LANP), the radiology department at Baylor College of Medicine (BCM) and the University of Texas MD Anderson Cancer Center. The group will investigate how well the nanoparticles work as: imaging agents, cell targeting, testing and treatment of the body before and after procedure, and therapeutic agents.

↑ Back to TechConnect News™

Event Spotlights

DITAC
Austin, TX, December 1-3, 2015
DES
Austin, TX, December 1-3, 2015
 

Annual Meeting

TechConnect World 2015
Washington, DC, May 22-25, 2016